Azapropazone
From Infogalactic: the planetary knowledge core
 |
|
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo[1,2-a][1,2,4]benzotriazine-1,3(2H)-dione
|
|
| Clinical data | |
| Trade names | Rheumox |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
|
| Pharmacokinetic data | |
| Biological half-life | 20 hours |
| Identifiers | |
| CAS Number | 13539-59-8  |
| ATC code | M01AX04 (WHO) |
| PubChem | CID: 26098 |
| ChemSpider | 24310  |
| UNII | K2VOT966ZI |
| KEGG | D02966 |
| ChEBI | CHEBI:38010 |
| ChEMBL | CHEMBL1231131 |
| Chemical data | |
| Formula | C16H20N4O2 |
| Molecular mass | 300.36 g/mol |
|
|
|
|
| (what is this?) (verify) |
|
Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]
It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.
Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]
References
- ↑ http://home.intekom.com/pharm/cont_eth/rheumox.html
- ↑ http://www.patient.co.uk/showdoc/30002267/
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
